NCT07390877

Brief Summary

Cognitive and metacognitive remediation in addiction treatment: Value of Adding a cognitive remediation program to improve overall self-efficacy in patients with alcohol use disorder.

Trial Health

63
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
130

participants targeted

Target at P50-P75 for not_applicable

Timeline
32mo left

Started Feb 2026

Typical duration for not_applicable

Geographic Reach
1 country

6 active sites

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress8%
Feb 2026Jan 2029

First Submitted

Initial submission to the registry

December 5, 2025

Completed
2 months until next milestone

First Posted

Study publicly available on registry

February 5, 2026

Completed
23 days until next milestone

Study Start

First participant enrolled

February 28, 2026

Completed
1.9 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 15, 2028

Expected
1 year until next milestone

Study Completion

Last participant's last visit for all outcomes

January 15, 2029

Last Updated

February 19, 2026

Status Verified

December 1, 2025

Enrollment Period

1.9 years

First QC Date

December 5, 2025

Last Update Submit

February 17, 2026

Conditions

Keywords

Alcohol use disorderCognitive remediationSelf-efficacity

Outcome Measures

Primary Outcomes (1)

  • Change in General Self-Efficacy (SGSES-fr)

    The primary outcome measure will be the change in the overall score on the SGSES-fr scale between the pre-treatment assessment (V1) and the immediate post-treatment assessment (V2). The advantage of this scale over other self-efficacy scales is that it is not linked to specific situations or behaviors, but represents a general measure. The minimum value is 10 and the maximum value is 40. 10 is a high outcome 40 is a low outcome It is expected that this score will increase between V1 and V2.

    6 months

Study Arms (2)

R'COMET treatment program (cognitive remediation program)

EXPERIMENTAL

The program will include 10 weekly sessions in an open group format to facilitate the patient's engagement in the treatment program (the patient may join the group at any time). The sessions will last 2 hours, ideally with 4-5 patients per session. Each session will include group and/or individual cognitive exercises to encourage interaction and the sharing of experiences, while also providing individualized and tailored support for each participant. Every cognitive exercise will be approached from a motivational perspective. The exercises offered during the sessions will be combined with systematic verbalization of strategies and emotional states, as well as psychoeducational, body-based, non-verbal communication, and cognitive-behavioral techniques. The proposed strategies will draw on both retrieval and compensatory approaches depending on the individual profiles. A progress booklet will be given to the patient.

Behavioral: cognitive remediation group

Relaxation control program

ACTIVE COMPARATOR

The relaxation program consists of 10 weekly sessions lasting 2 hours, held in open groups of 4 to 5 participants. Each session follows a flexible structure with several phases: a welcome moment where participants identify and express their feelings, a musical listening period to help them settle into the session, and a self-massage activity to promote bodily awareness. This is followed by a guided relaxation phase-either passive or active-to encourage physical and mental release. At the end of the session, a different breathing exercise is introduced each week so participants can discover which technique suits them best. The session concludes with a verbalization period, allowing everyone to share their sensations and impressions in a supportive, non-judgmental environment. Participants are encouraged to practice the exercises independently as well .

Behavioral: Relaxation control program

Interventions

The program will include 10 weekly sessions in an open group format to facilitate the patient's engagement in the treatment program (the patient may join the group at any time). The sessions will last 2 hours, ideally with 4-5 patients per session. Each session will include group and/or individual cognitive exercises to encourage interaction and the sharing of experiences, while also providing individualized and tailored support for each participant. Every cognitive exercise will be approached from a motivational perspective. The exercises offered during the sessions will be combined with systematic verbalization of strategies and emotional states, as well as psychoeducational, body-based, non-verbal communication, and cognitive-behavioral techniques. The proposed strategies will draw on both retrieval and compensatory approaches depending on the individual profiles.

R'COMET treatment program (cognitive remediation program)

The relaxation program consists of 10 weekly sessions lasting 2 hours, held in open groups of 4 to 5 participants. Each session follows a flexible structure with several phases: a welcome moment where participants identify and express their feelings, a musical listening period to help them settle into the session, and a self-massage activity to promote bodily awareness. This is followed by a guided relaxation phase-either passive or active-to encourage physical and mental release. At the end of the session, a different breathing exercise is introduced each week so participants can discover which technique suits them best. The session concludes with a verbalization period, allowing everyone to share their sensations and impressions in a supportive, non-judgmental environment. Participants are encouraged to practice the exercises independently as well .

Relaxation control program

Eligibility Criteria

Age18 Years - 65 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Aged between 18 and 65 (inclusive).
  • Native French speaker or educated in French.
  • Primary diagnosis of AUD according to DSM-5, with or without comorbid SUD.
  • Currently in withdrawal: abstinent for at least 7 days and no more than 30 days.
  • At least mild cognitive impairment, as measured by the BEARNI scale (mild impairment on the global scale or score below the threshold on at least one of the subtests).

You may not qualify if:

  • Guardianship.
  • Simultaneous participation in a cognitive rehabilitation group, an ETP programme or a mindfulness meditation group.
  • Presence of neurodegenerative disease, Korsakoff's syndrome, mental retardation, or any other condition that may significantly interfere with the completion of assessments, as determined by the clinician.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (6)

EPSM Epsylan

Blain, France

Location

EPSM Georges Daumézon

Bouguenais, France

Location

CHRU Brest

Brest, France

Location

HIA

Brest, France

Location

CHU de Nantes

Nantes, France

Location

EPSM du Finistère Sud

Quimper, France

Location

MeSH Terms

Conditions

Alcoholism

Condition Hierarchy (Ancestors)

Alcohol-Related DisordersSubstance-Related DisordersChemically-Induced DisordersMental Disorders

Study Officials

  • Leslie TOUATI-HUREAU

    Nantes University Hospital

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Gaëlle CHALLET

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
PARTICIPANT
Masking Details
Single
Purpose
OTHER
Intervention Model
PARALLEL
Model Details: This is a controlled study in which participants are randomized into two parallel groups: cognitive remediation group (R'COMET) or relaxation group (comparator).
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

December 5, 2025

First Posted

February 5, 2026

Study Start

February 28, 2026

Primary Completion (Estimated)

January 15, 2028

Study Completion (Estimated)

January 15, 2029

Last Updated

February 19, 2026

Record last verified: 2025-12

Data Sharing

IPD Sharing
Will not share

Locations